As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Han A. Koh is a clinical oncologist and medical director of the Cancer Clinical Trials Access Program, which connects innovative cancer clinical trials to Kaiser Permanente oncology patients. The program affords Kaiser Permanente members access to cutting-edge cancer therapies being researched in leading academic medical centers around the country. Dr. Koh is the specialty lead for clinical trials in lung cancer. At the Kaiser Permanente Downey Medical Center, Dr. Koh is chair of the Medical ...
Emergency physicians at Kaiser Permanente hospitals in Southern California reduced hospital admissions and cardiac stress testing by using new criteria to assess the level of risk patients with chest pain have for subsequent cardiac events. The emergency department assessment was implemented across Kaiser Permanente Southern California and has improved the quality and efficiency of care ...
Organizations like Kaiser Permanente can make continuous improvements in the quality, safety, and value of patient care and at the same time contribute to scientific knowledge nationally and internationally by embedding researchers in their health care systems. This week, leaders in the movement toward learning health care systems will meet in Pasadena, Calif. to create ...
Hospitalized patients who received the flu vaccine had no increased risk of outpatient visits or hospital readmission within seven days of discharge, according to a Kaiser Permanente study published in Mayo Clinic Proceedings. The study also showed that vaccinating hospital patients did not increase the risk of fever or rates of laboratory evaluations for infection. ...
Kaiser Permanente research published today in the American Journal of Preventive Medicine found if patients with hypertension taking prescribed medications experience unusually low blood pressures — systolic blood pressure under 110mmHg — they are twice as likely to experience a fall or faint as patients whose treated blood pressure remains 110mmHg and above. This research ...
We asked these 5 questions of Jean M. Lawrence, ScD, MPH, MSSA, senior research scientist with the Department of Research & Evaluation in Southern California. Why did you choose to devote your career to researching ways women and children can live better, healthier lives? I’ve always been interested in women’s and children’s health and started my ...
In September, the Department of Research & Evaluation will host the American College of Epidemiology Annual Meeting, which will address the theme of “Real-World Epidemiologic Evidence in Policy and Practice.”
Details on the conference and registration information will be released in early May. Please check the meeting webpage for updates on key dates and deadlines.
The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.
The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.
